NRSN

NeuroSense Therapeutics Ltd.

Healthcare · Biotechnology

$309.58 sample

+3.64 (+1.19%) 1D

Market cap

$1.29T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-08

Alerts

8

Price$309.58 +4.24% 3M daily closessample

323.33296.99

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 12INSInsider sell: General Counsel
Oct 01INSInsider sell: Director
Sep 24INSInsider sell: Chief Executive Officer
Sep 17INSInsider sell: Director
Sep 08SEC8-K filed: material event
Sep 01INSInsider buy: 10% owner
Aug 25INSInsider sell: Chief Financial Officer
Aug 17INSInsider sell: EVP, Operations

Sign up to see the real NRSN record →

Company facts

SEC EDGAR registration

Name: NeuroSense Therapeutics Ltd.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -56sample, -100 to +100
Reporting currency: USD

Who is positioning in NRSN

sample

Insiders: 13 insider transactions over 90 days, net selling, $189.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 27 funds hold $11.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$66.5B +15.4% y/y

Q4 2024Q3 2026

Inventory$40.5B +7.1% y/y

Q4 2024Q3 2026

Accounts receivable$31.1B +18.3% y/y

Q4 2024Q3 2026

Total debt$84.1B +19.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $615.2B -12.1% 3M
Sample peer B: $846.9B -3.8% 3M
Sample peer C: $660.3B -10.3% 3M
Sample peer D: $1.07T -12.1% 3M
Sample peer E: $771.1B -4.3% 3M